Treatment Outcomes in a Centralized Specialty Clinic for Hepatitis C Virus Are Comparable with Those from Clinical Trials
BACKGROUND: Outcomes from industry-sponsored registration trials are often considered to be more favourable than those achieved in clinical practice because patients involved in the former are highly selected and supported, but it is not known if this impression is valid.
Saved in:
| Main Authors: | Kelly DE Kaita, Stephen Wong, Eberhard Renner, Gerald Y Minuk |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2006-01-01
|
| Series: | Canadian Journal of Gastroenterology |
| Online Access: | http://dx.doi.org/10.1155/2006/148962 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Risk Factors for Hepatitis C Virus Infection in Canadian Patients with Chronic Type C Hepatitis
by: GY Minuk, et al.
Published: (1995-01-01) -
Autoimmune Hepatitis in a North American Aboriginal/First Nations Population
by: GY Minuk, et al.
Published: (2008-01-01) -
Pretreatment Resistance to Hepatitis C Virus Protease Inhibitors Boceprevir/Telaprevir in Hepatitis C Subgenotype 1A-Infected Patients from Manitoba
by: Anton Andonov, et al.
Published: (2013-01-01) -
Management of Chronic Hepatitis C: Consensus Guidelines
by: Morris Sherman, et al.
Published: (2007-01-01) -
Treatment of Chronic Hepatitis C in a Canadian Aboriginal Population: Results from the Prairie Study
by: Gerald Yosel Minuk, et al.
Published: (2013-01-01)